Vaccine News and Research

Latest Vaccine News and Research

Novel mRNA vaccines encoding Monkeypox virus proteins show promise in preclinical studies

In a recent study posted to the bioRxiv* preprint server, researchers in China demonstrated the efficacy of three messenger ribonucleic acid (mRNA) technology-based Monkeypox virus (MPXV) vaccines in combating a lethal Vaccinia virus (VACV) challenge in mice models.

22 Nov 2022

Ultrapotent IgM antibodies isolated from a pregnant woman with Zika virus show promise as an immunotherapy

Zika virus (ZIKV) infection is a potentially teratogenic illness, causing up to one in seven infants born to infected mothers to suffer neurodevelopmental deficits. A new study published in the journal Cell shows that some mothers escape injury to their babies because they develop a highly potent neutralizing antibody.

22 Nov 2022

Plant-based monoclonal antibody increases potency of antibody cocktail against SARS-CoV-2 Omicron variant

A novel mAb against the SARS-CoV-2 RBD through a hybridoma technique, followed by chimerization and expression in plants.

22 Nov 2022

Shingles linked with higher long-term risk of major cardiovascular event

A new study by investigators from Brigham and Women's Hospital, a founding member of the Mass General Brigham healthcare system, demonstrated that shingles, also known as herpes zoster, is associated with an almost 30% higher long-term risk of a major cardiovascular event such a stroke or heart attack.

22 Nov 2022

Experts highlight the expanding presence and emerging risks from three endemic fungal diseases

Infectious diseases expert George Thompson has been studying and treating fungal diseases for over two decades. He monitors their spread, symptoms and relative risks.

22 Nov 2022

Effects of implemented vaccine rollout strategies on spread of SARS-CoV-2, subsequent global burden of disease, and emergence of novel variants

Researchers conducted a retrospective analysis to investigate the impact of vaccine-sharing strategies on the heterogenous global distribution of COVID-19 vaccines.

22 Nov 2022

Approved and developing passive and active immunizations against respiratory syncytial virus in childhood and pregnancy

Researchers explored active and passive vaccination among children against respiratory syncytial virus (RSV).

22 Nov 2022

US experienced higher COVID-19 mortality during delta and omicron waves

A recent study estimates coronavirus disease 2019-related mortality and excess all-cause mortality in the US and 20 peer countries during the delta and omicron waves of infection.

22 Nov 2022

America's health care organizations remind the public about vaccinations and early treatment for COVID-19, influenza

Given the anticipated increase in COVID-19 and influenza cases this fall and winter, America's healthcare professional organizations are coming together to remind the public of the importance of vaccinations and early treatment.

21 Nov 2022

Additional mRNA COVID vaccine doses could salvage antibody responses in blood cancer patients

A third COVID-19 vaccine dose in this patients with blood cancers could enhance their antibody responses against SARS-CoV-2

21 Nov 2022

The Native Antigen Company introduces new range of influenza antigens

The Native Antigen Company (part of LGC Clinical Diagnostics), one of the world’s leading suppliers of reagents that enables research into vaccines and diagnostics for emerging and endemic infectious diseases, today announced the commercial launch of its latest range of influenza antigens for the southern hemisphere’s 2023 flu season.

From The Native Antigen Company 21 Nov 2022

New method for isolating Omicron subvariant and evaluating resistance to therapeutic and vaccine-elicited antibodies

Researchers demonstrated a viral amplification procedure to isolate the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron subvariants.

21 Nov 2022

Some parents may delay or avoid talking about vaccines with their child’s primary care provider

Parents may not always turn to health professionals for vaccine advice – and a small subset could even be avoiding the conversation – a new national poll suggests.

21 Nov 2022

Tackling Antimicrobial Resistance; A Conversation with the World Health Organisation

For World Antimicrobial Awareness Week (WAAW), we speak to Silvia Bertagnolio from the WHO, about the importance of raising awareness of antimicrobial resistance.

21 Nov 2022

SARS-CoV-2 infection and mRNA vaccination prime transcriptionally distinct CD4+ T cell memory landscapes

Researchers reported that SARS-CoV-2 infection and mRNA vaccination induce distinct memory T cells.

21 Nov 2022

Does influenza vaccination reduce death and vascular events in patients with heart failure?

Researchers conducted a placebo-controlled, double-blind clinical trial to assess whether influenza vaccination effectively reduced vascular events and mortality among patients with heart failure.

21 Nov 2022

New discovery increases understanding of the effects of narcolepsy on the brain

Narcolepsy alters the pulsations that maintain the brain’s waste clearance system, shows a new study from the University of Oulu. The researchers’ discovery increases our understanding of the effects of narcolepsy on the brain, and may also help in the diagnosis of the disease.

21 Nov 2022

Rutgers scientists develop new approach to effectively shut down viral infections

Rutgers scientists have developed a new approach to stopping viral infections: a so-called live-attenuated, replication-defective DNA virus vaccine that uses a compound known as centanamycin to generate an altered virus for vaccine development.

20 Nov 2022

Unusual Zika virus-specific antibody exhibits ultrapotent neutralization

An unusual type of antibody that even at miniscule levels neutralizes the Zika virus and renders the virus infection undetectable in preclinical models has been identified by a team led by Weill Cornell Medicine, NewYork-Presbyterian and National Institutes of Health (NIH) investigators.

20 Nov 2022

Preparing for epidemics now and in the future

The World Health Organization (WHO) recently conducted a virtual press conference on global health emergencies on November 16, 2022. Margaret Harris hosted the conference at WHO Headquarters in Geneva. In addition, a broad panel of technical experts was present online and offline for discussion.

20 Nov 2022

Vaccine News and Research

Latest Vaccine News and Research

Novel mRNA vaccines encoding Monkeypox virus proteins show promise in preclinical studies

Ultrapotent IgM antibodies isolated from a pregnant woman with Zika virus show promise as an immunotherapy

Plant-based monoclonal antibody increases potency of antibody cocktail against SARS-CoV-2 Omicron variant

Shingles linked with higher long-term risk of major cardiovascular event

Experts highlight the expanding presence and emerging risks from three endemic fungal diseases

Effects of implemented vaccine rollout strategies on spread of SARS-CoV-2, subsequent global burden of disease, and emergence of novel variants

Approved and developing passive and active immunizations against respiratory syncytial virus in childhood and pregnancy

US experienced higher COVID-19 mortality during delta and omicron waves

America's health care organizations remind the public about vaccinations and early treatment for COVID-19, influenza

Additional mRNA COVID vaccine doses could salvage antibody responses in blood cancer patients

The Native Antigen Company introduces new range of influenza antigens

New method for isolating Omicron subvariant and evaluating resistance to therapeutic and vaccine-elicited antibodies

Some parents may delay or avoid talking about vaccines with their child’s primary care provider

Tackling Antimicrobial Resistance; A Conversation with the World Health Organisation

SARS-CoV-2 infection and mRNA vaccination prime transcriptionally distinct CD4+ T cell memory landscapes

Does influenza vaccination reduce death and vascular events in patients with heart failure?

New discovery increases understanding of the effects of narcolepsy on the brain

Rutgers scientists develop new approach to effectively shut down viral infections

Unusual Zika virus-specific antibody exhibits ultrapotent neutralization

Preparing for epidemics now and in the future

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in